Isthmus Partners LLC Invests $701,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Isthmus Partners LLC purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 9,622 shares of the company's stock, valued at approximately $701,000.

A number of other large investors have also recently bought and sold shares of the stock. Cromwell Holdings LLC raised its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new position in Henry Schein in the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein during the 2nd quarter worth $37,000. Blue Trust Inc. boosted its position in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after buying an additional 475 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its position in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after acquiring an additional 346 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on HSIC shares. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Robert W. Baird lowered their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research report on Wednesday, August 7th. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a report on Monday, August 12th. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Henry Schein presently has a consensus rating of "Moderate Buy" and an average target price of $79.38.

Henry Schein Stock Down 0.8 %

Shares of Henry Schein stock traded down $0.61 during trading on Friday, reaching $77.05. The stock had a trading volume of 608,569 shares, compared to its average volume of 1,397,171. The stock has a fifty day moving average price of $71.48 and a two-hundred day moving average price of $69.92. The company has a market capitalization of $9.61 billion, a price-to-earnings ratio of 31.71, a P/E/G ratio of 2.23 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue for the quarter was up .4% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS. Sell-side analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.